CLINICAL_TRIALS
trial_result
· 2025-12-04
Clinical Trial Update: Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis [Phase 2]
Summary
Phase 2 efficacy trial of EVO301 in moderate-to-severe atopic dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evommune, Inc. | Conditions: Atopic Dermatitis (AD), Eczema | Phase 2 | Status: COMPLETED